Tag Archives: CPHI Frankfurt

New Distribution Agreement Between Brenntag and ArcticZymes Strengthens European Access to Advanced Enzymes for Biopharma Production

(IN BRIEF) Brenntag has signed an exclusive European distribution agreement with ArcticZymes AS for its line of salt-active nucleases—SAN HQ, SAN-HQ GMP, M-SAN HQ, and M-SAN HQ GMP—used in gene therapy, vaccine manufacturing, and bioprocessing. Signed during the CPHI fair … Read the full press release

SCHOTT Pharma debuts world’s first 5.5 ml prefillable staked-needle glass syringe, paving the way for next-generation biologic therapies at home

(IN BRIEF) SCHOTT Pharma has launched the industry’s first 5.5 ml prefillable staked-needle glass syringe, expanding its syriQ BioPure® platform to support biologic therapies designed for home administration. The syringe integrates seamlessly with Ypsomed’s YpsoMate® 5.5 ml autoinjector and Datwyler’s … Read the full press release

SCHOTT Pharma Sets New Standard with ISO-Compliant Ready-to-Use Polymer Cartridge for Biologics

IN BRIEF) SCHOTT Pharma has introduced the SCHOTT TOPPAC® cartridge, the first ready-to-use polymer cartridge to meet ISO dimensions, offering exceptional dimensional precision and broad device compatibility for injection systems such as pens. Made from COC and designed for sensitive … Read the full press release